With R&D platforms including peptides, oligonucleotides, conjugated drugs, high performance liquid chromatography, and Tides analysis, the Porton Tides CDMO Services Platform is committed to providing integrated CMC solutions for global customers, covering all types of new drugs from pre-clinical to …
We have a professional technology platform and an experienced team to provide one-stop PROTAC drugs technological solutions to global customers
…
Porton has a professional technology platform and an experienced team to provide global clients with CMC solutions for radiopharmaceutical precursors and cold drugs. We are committed to becoming the leading RDC CDMO company in China.
…
As a subsidiary of Porton Pharma Solutions, a globally recognized CDMO, Porton Biologics and Conjugates CDMO Platform offers comprehensive, one-stop drug development and manufacturing services for biologics and conjugates, including ADCs, AOCs, PDCs, RDC, etc.
…
With over 4300 employees, Porton Pharma Solutions, a global company with R&D and GMP-compliant manufacturing facilities across the US, EU and China, provides customer-centric innovative and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, …
J-STAR provides high quality scientific and technical ability in small molecule problem solving including impurity/degradant isolation and structure elucidation. We have over 85 years of cumulative expertise in NMR/MS data acquisition and interpretation and are equipped with state-of-the-art instrumentation typically …
With the ability to develop both Drug Substance (DS) and Drug product (DP) under the same umbrella, our team enjoys a synergism absent in most CROs. The ability to bridge the DS/DP interface is a major competitive advantage, and we …
